Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkad345 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Chin Fen Neoh und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia. Hauptthemen laut MEDLINE: Antifungal Agents, Scedosporium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: F2G Ltd.
Abstract (Originalsprache)
Background
Little is known about the short- and long-term healthcare costs of invasive Scedosporium/Lomentospora prolificans infections, particularly in patient groups without haematological malignancy. This study investigated excess index hospitalization costs and cumulative costs of these infections. The predictors of excess cost and length of stay (LOS) of index hospitalization were determined. These estimates serve as valuable inputs for cost-effectiveness models of novel antifungal agents.
Methods
A retrospective case-control study was conducted at six Australian hospitals. Cases of proven/probable invasive Scedosporium/L. prolificans infections between 2011 and 2021 (n = 34) were matched with controls (n = 66) by predefined criteria. Cost data were retrieved from activity-based costing systems and analysis was performed from the Australian public hospital perspective. All costs were presented in 2022 Australian dollars (AUD). Median regression analysis was used to adjust excess costs of index hospitalization whereas cumulative costs up to 1.5 years follow-up were estimated using interval-partitioned survival probabilities.
Results
Invasive Scedosporium/L. prolificans infections were independently associated with an adjusted median excess cost of AUD36 422 (P = 0.003) and LOS of 16.27 days (P < 0.001) during index hospitalization. Inpatient stay was the major cost driver (42.7%), followed by pharmacy cost, of which antifungal agents comprised 23.8% of the total cost. Allogeneic haematopoietic stem cell transplant increased the excess cost (P = 0.013) and prolonged LOS (P < 0.001) whereas inpatient death within ≤28 days reduced both cost (P = 0.001) and LOS (P < 0.001). The median cumulative cost increased substantially to AUD203 292 over 1.5 years in cases with Scedosporium/L. prolificans infections.
Conclusions
The economic burden associated with invasive Scedosporium/L. prolificans infections is substantial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
- Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Westmead Hospital, Sydney, Australia.
- The University of Sydney Institute of Infectious Diseases, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
- The National Centre for Antimicrobial Stewardship, The Peter Doherty Institute for Infections and Immunity, Melbourne, Australia.
ORCID-Profile: David C M Kong, Jason A Trubiano, Monica A Slavin
Förderung
- F2G Ltd
Zitieren
APA
Neoh, C. F., Chen, S. C. A., Kong, D. C. M., Hamilton, K., Nguyen, Q. A., Spelman, T., Tew, M., Harvey, E. L., Ho, S. A., Saunders, N. R., Tennakoon, S., Crowe, A., Marriott, D., Trubiano, J. A., & Slavin, M. A. (2024). Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad345
Vancouver
Neoh CF, Chen SCA, Kong DCM, Hamilton K, Nguyen QA, Spelman T, et al. Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkad345
BibTeX
@article{Neoh2024,
author = {Neoh, Chin Fen and Chen, Sharon C A and Kong, David C M and Hamilton, Kate and Nguyen, Quoc A and Spelman, Tim and Tew, Michelle and Harvey, Emma L and Ho, Su Ann and Saunders, Natalie R and Tennakoon, Surekha and Crowe, Amy and Marriott, Debbie and Trubiano, Jason A and Slavin, Monica A},
title = {Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkad345}
}
EUVIMED